Handelsbanken Fonder AB increased its stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 65.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 39,600 shares of the company’s stock after acquiring an additional 15,700 shares during the period. Handelsbanken Fonder AB’s holdings in Ryan Specialty were worth $2,232,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. Golden State Wealth Management LLC raised its stake in shares of Ryan Specialty by 10,975.0% during the 2nd quarter. Golden State Wealth Management LLC now owns 443 shares of the company’s stock worth $30,000 after purchasing an additional 439 shares in the last quarter. MAI Capital Management grew its stake in shares of Ryan Specialty by 65.3% in the second quarter. MAI Capital Management now owns 476 shares of the company’s stock valued at $32,000 after buying an additional 188 shares in the last quarter. Fifth Third Bancorp increased its holdings in Ryan Specialty by 65.4% during the third quarter. Fifth Third Bancorp now owns 612 shares of the company’s stock worth $34,000 after buying an additional 242 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its position in Ryan Specialty by 83.7% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 599 shares of the company’s stock worth $35,000 after acquiring an additional 273 shares in the last quarter. Finally, Hantz Financial Services Inc. lifted its stake in Ryan Specialty by 878.2% in the third quarter. Hantz Financial Services Inc. now owns 851 shares of the company’s stock valued at $48,000 after acquiring an additional 764 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors.
Ryan Specialty Price Performance
Shares of NYSE RYAN opened at $39.51 on Thursday. The firm has a market cap of $10.44 billion, a P/E ratio of 94.07, a price-to-earnings-growth ratio of 1.04 and a beta of 0.65. The business’s 50 day moving average is $46.66 and its 200-day moving average is $52.20. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62. Ryan Specialty Holdings Inc. has a 1-year low of $37.29 and a 1-year high of $77.16.
Ryan Specialty Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 24th will be paid a $0.13 dividend. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date is Tuesday, February 24th. This represents a $0.52 annualized dividend and a yield of 1.3%. Ryan Specialty’s dividend payout ratio is presently 123.81%.
Insider Transactions at Ryan Specialty
In related news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of the stock in a transaction on Monday, February 23rd. The shares were purchased at an average price of $39.96 per share, for a total transaction of $1,018,980.00. Following the purchase, the director directly owned 428,295 shares in the company, valued at approximately $17,114,668.20. The trade was a 6.33% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Timothy William Turner sold 129,570 shares of Ryan Specialty stock in a transaction on Friday, December 12th. The shares were sold at an average price of $53.61, for a total value of $6,946,247.70. Following the completion of the transaction, the chief executive officer directly owned 12,553 shares of the company’s stock, valued at $672,966.33. This represents a 91.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 52.21% of the company’s stock.
Analysts Set New Price Targets
RYAN has been the topic of several recent analyst reports. The Goldman Sachs Group set a $61.00 price objective on shares of Ryan Specialty in a research note on Wednesday, January 7th. BMO Capital Markets cut Ryan Specialty from an “outperform” rating to a “market perform” rating and reduced their price target for the stock from $66.00 to $43.00 in a report on Wednesday, February 25th. Morgan Stanley dropped their price objective on Ryan Specialty from $61.00 to $55.00 and set an “overweight” rating on the stock in a research note on Monday, February 23rd. Cantor Fitzgerald reduced their target price on Ryan Specialty from $52.00 to $45.00 and set a “neutral” rating for the company in a research note on Tuesday, February 17th. Finally, Wells Fargo & Company dropped their price target on Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $56.87.
Check Out Our Latest Analysis on RYAN
Ryan Specialty Company Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Featured Articles
- Five stocks we like better than Ryan Specialty
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
